Literature DB >> 16581354

Physical symptom disorder: a simpler diagnostic category for somatization-spectrum conditions.

Kurt Kroenke1.   

Abstract

OBJECTIVE: To propose a simpler, more empiric, and patient-centered category for classifying physical symptoms that are "etiologically neutral," that is, not reliant on the assumption that symptoms that is poorly explained from a medical standpoint must de facto be psychological in origin.
METHODS: Theoretical analysis, narrative review, and proposal.
RESULTS: Studies have revealed several limitations in the current classification of somatoform disorders, including the poor reliability of lifetime symptom recall, the difficulty in adjudicating physical versus psychological explanations, and the stigma in assigning patients with medically unexplained symptoms to an Axis I psychiatric disorder. Physical symptom disorder (PSD) is proposed as a diagnostic category that would reside on Axis III (rather than Axis I) and replace somatization disorder, undifferentiated somatoform disorder, and pain disorder. PSD would consist of one or more physical symptoms currently present, not fully explainable by another medical or psychiatric disorder (with the exception of functional somatic syndromes), causing functional impairment. Duration must be at least 6 months, and severity could be graded as mild, moderate, or severe using a 15-symptom checklist (PHQ-15). Finally, the type of symptoms or symptom syndromes present in the patient could be specified.
CONCLUSIONS: PSD should be considered as a simpler and more inclusive diagnosis to replace several somatoform diagnoses currently in use.

Entities:  

Mesh:

Year:  2006        PMID: 16581354     DOI: 10.1016/j.jpsychores.2006.01.022

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  33 in total

1.  [Somatoform disorders and functional somatic syndromes].

Authors:  C Lahmann; P Henningsen; A Dinkel
Journal:  Nervenarzt       Date:  2010-11       Impact factor: 1.214

2.  Medically unexplainable somatic symptoms: a coat with many psychiatric colors.

Authors:  Randy A Sansone; Lori A Sansone
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2010

3.  [Somatoform disorders. Clinical evidence, etiology, pathogenesis, and therapy].

Authors:  H P Kapfhammer
Journal:  Nervenarzt       Date:  2008-01       Impact factor: 1.214

Review 4.  Pharmacological and psychosocial management of mental, neurological and substance use disorders in low- and middle-income countries: issues and current strategies.

Authors:  Jair de Jesus Mari; Luís Fernando Tófoli; Cristiano Noto; Li M Li; Alessandra Diehl; Angélica M Claudino; Mario F Juruena
Journal:  Drugs       Date:  2013-09       Impact factor: 9.546

5.  Modern health worries, somatosensory amplification and subjective symptoms: a longitudinal study : a longitudinal study.

Authors:  Ferenc Köteles; Péter Simor
Journal:  Int J Behav Med       Date:  2013-03

6.  [Definition, classification and diagnosis of fibromyalgia syndrome].

Authors:  W Eich; W Häuser; E Friedel; A Klement; M Herrmann; F Petzke; M Offenbächer; M Schiltenwolf; C Sommer; T Tölle; P Henningsen
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

7.  The medically unexplained revisited.

Authors:  Thor Eirik Eriksen; Anna Luise Kirkengen; Arne Johan Vetlesen
Journal:  Med Health Care Philos       Date:  2013-08

8.  The association of depression and anxiety with health-related quality of life in cancer patients with depression and/or pain.

Authors:  Linda F Brown; Kurt Kroenke; Dale E Theobald; Jingwei Wu; Wanzhu Tu
Journal:  Psychooncology       Date:  2010-07       Impact factor: 3.894

9.  Affect School for chronic benign pain patients showed improved alexithymia assessments with TAS-20.

Authors:  Eva O Melin; Hans O Thulesius; Bengt A Persson
Journal:  Biopsychosoc Med       Date:  2010-06-04

10.  Children's Somatization Inventory: psychometric properties of the revised form (CSI-24).

Authors:  Lynn S Walker; Joy E Beck; Judy Garber; Warren Lambert
Journal:  J Pediatr Psychol       Date:  2008-09-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.